US Federal 2025-2026 Regular Session

US Federal House Bill HB2005

Introduced
 
Introduced
3/10/25  

Caption

DMEPOS Relief Act of 2025

Summary

HB2005, titled the DMEPOS Relief Act of 2025, would direct the Secretary of Health and Human Services to adjust Medicare payment rules for certain durable medical equipment and related supplies that were formerly included in round 2021 of the DMEPOS competitive bidding program. The bill focuses on how Medicare reimburses suppliers in non-competitive bidding areas, extending a transition payment rule through December 31, 2025 for areas other than rural or noncontiguous areas, and delaying a separate regulatory provision until January 1, 2026. In practical terms, the bill is intended to provide temporary relief to suppliers and beneficiaries affected by changes in Medicare payment rates for durable medical equipment. It would require HHS to apply the specified transition rule to all applicable items and services in the covered areas and authorizes the Secretary to implement the changes by program instruction or other administrative means. The bill does not create a new benefit category, but instead modifies the timing and application of existing Medicare payment regulations.

Impact

The bill would affect Medicare payment administration under the DMEPOS competitive bidding framework by temporarily preserving or extending higher or transitional reimbursement rules for certain durable medical equipment. It would alter the implementation timeline of federal regulations at 42 C.F.R. ยง 414.210(g)(9)(v) and (vi), with direct consequences for suppliers of durable medical equipment, Medicare contractors, and beneficiaries who rely on these items. Because it is framed as a directive to HHS, the bill would primarily change federal administrative practice rather than amend the Medicare statute itself.

Sentiment

The available context suggests generally supportive sentiment around the bill, with bipartisan sponsorship from Representatives Miller-Meeks, Tonko, Feenstra, and Panetta. The bill was introduced as a relief measure, indicating a shared concern about the effects of the competitive bidding transition on access and payment stability for durable medical equipment. No committee transcripts or recorded votes were provided, so there is no evidence of formal opposition in the available record.

Contention

The main point of contention is likely the balance between payment relief and Medicare cost control. Supporters appear to favor extending transitional payment rules to avoid disruption for suppliers and patients, while potential critics could argue that delaying competitive bidding-related payment changes may increase Medicare spending or slow implementation of market-based pricing reforms. Another possible issue is the geographic scope of the relief, since the bill distinguishes between areas other than rural or noncontiguous areas and the broader set of all areas, which may raise questions about fairness and administrative complexity.

Companion Bills

US SB2951

Related Competitive Bidding Relief Act

Similar Bills

No similar bills found.